GLP-TZ 10MG

$ 60

Technical Identity: Tirzepatide
Alternative Names: Tirz, TRZ, LY3298176
Catalog Shorthand: GLP-TZ
CAS #: 2023788-19-2
Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight (M.W.): Approximately 4813.5 g/mol
Length: 39 amino-acid residues
Product Type: Modified Synthetic Research Peptide

Category:

Description

GLP-TZ is a catalog designation used for Tirzepatide, a modified synthetic 39-residue peptide supplied for controlled laboratory, analytical, and scientific research.

The term GLP-TZ should be treated as a catalog shorthand rather than a standardized scientific name. Tirzepatide has its own defined molecular identity, including a peptide backbone, non-standard amino-acid features, linker chemistry, and a lipid-associated side chain.

These structural modifications form an integral part of the molecule and should be included when establishing its complete analytical identity.

Research Applications

GLP-TZ / Tirzepatide may be examined in controlled non-clinical research involving:

  • Modified peptide characterization
  • Ligand-receptor interaction studies
  • Molecular signaling research
  • Structure-function analysis
  • Lipidated peptide characterization
  • Comparative analytical studies
  • Stability assessment
  • Non-clinical biochemical and cellular models

Experimental observations should remain specific to the applicable research system and should not be interpreted as evidence of weight-management benefit, metabolic benefit, therapeutic effectiveness, or clinical suitability.

Structural Information

Tirzepatide is a 39-residue modified peptide whose complete molecular identity includes:

  • Defined peptide backbone
  • Non-standard amino-acid features
  • Lipid-associated side chain
  • Linker chemistry
  • C-terminal amidation

A simplified amino-acid sequence does not fully represent these structural features.

Analytical Identification

Relevant analytical characterization may include:

  • Peptide identity confirmation
  • Molecular mass assessment
  • Modified-residue verification
  • Lipid-side-chain confirmation
  • C-terminal modification verification
  • Chromatographic purity testing
  • Structural characterization
  • Intact-mass analysis
  • Lot-specific quality testing

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Tirzepatide identity
  • GLP-TZ catalog designation
  • CAS number
  • Molecular formula
  • Molecular weight
  • Peptide length
  • Modified amino-acid residues
  • Lipid-associated side chain
  • Terminal modification
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific documentation should take precedence over generalized catalog terminology.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Handling should follow established laboratory procedures appropriate for modified research peptide materials.

Research Use Only

GLP-TZ / Tirzepatide is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, weight-management use, metabolic use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, metabolic, weight-related, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.

 

Reviews

There are no reviews yet.

Be the first to review “GLP-TZ 10MG”

Your email address will not be published. Required fields are marked *